Skip to content

EMERGENT BIOSOLUTIONS INC.

EBS

CIK 0001367644

← back to feed
Revenue (TTM)
$750.3M
−28.8% YoY Q1 Apr 2026
Net Income (TTM)
$114M
+127.6% YoY Q1 Apr 2026
EPS Diluted (TTM)
$1.95
+125.8% YoY Q1 Apr 2026
Gross Margin
46.4%
Q1 Apr 2026
Operating Margin
18.5%
Q1 Apr 2026
Net Margin
15.2%
Q1 Apr 2026
Free Cash Flow (TTM)
−$323.5M
Q1 Apr 2026
Cash
$160.3M
Q1 Apr 2026
Total Debt
$573.6M
Q1 Apr 2026
Shares Outstanding
51.6M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings